ライフサイエンスコーパス: metapneumovirus

1 za A, respiratory syncytial virus, and human metapneumovirus.

2 al methods, primarily rhinoviruses and human metapneumovirus.

3 tial virus (RSV), human bocavirus, and human metapneumovirus.

4 years nearly all people have been exposed to metapneumovirus.

5 h acute respiratory tract illness, for human metapneumovirus.

6 asonal coronavirus, parainfluenza, and human metapneumovirus.

7 re seen among sequences of the related human metapneumovirus.

8 ence except influenza A virus caught up with metapneumovirus.

9 es for parainfluenza virus, and 65 sites for metapneumovirus.

10 ry syncytial virus, parainfluenza virus, and metapneumovirus.

11 ere less frequent overall, followed by human metapneumoviruses.

12 enovirus (2), parainfluenza 4 (1), and human metapneumovirus (1).

13 luenza C, 1 respiratory syncytial virus B, 1 metapneumovirus, 1 adenovirus, and 1 enterovirus).

14 ), as were adenovirus (15% vs. 3%) and human metapneumovirus (15% vs. 8%).

15 rus (4.6 months [4.3 to 4.8]), as it was for metapneumovirus (4.8 months [4.4 to 5.1]).

16 iscordance was common for adenovirus (100%), metapneumovirus (44%), rhinovirus (34%), and parainfluen

17 (9%), respiratory syncytial virus (6%), and metapneumovirus (6%).

18 1, coronavirus NL63, coronavirus OC43, human metapneumovirus A and B, influenza A, influenza A H1, in

19 Human metapneumovirus, a leading cause of respiratory tract in

20 ot significantly affect infection with human metapneumovirus, a related virus.

21 fluenza virus (PIV), influenza virus (InfV), metapneumovirus, adenovirus (Ad), coronavirus, and enter

22 luenza viruses 1-4, influenza A and B, human metapneumovirus, adenovirus, and human rhinoviruses, cor

23 parainfluenza viruses 1, 2, 3, and 4; human metapneumovirus; adenovirus; enterovirus-rhinovirus; cor

24 -3, influenza viruses AH1, AH3, and B, human metapneumovirus, adenoviruses, and bocavirus) and 3 path

25 s well as respiratory syncytial virus, human metapneumovirus, adenoviruses, picornaviruses, and coron

26 enza, respiratory syncytial virus, and human metapneumovirus among patients with CAP of all ages prob

27 Avian metapneumovirus (AMPV) causes an acute respiratory disea

28 Avian metapneumovirus (AMPV) infects the respiratory and repro

29 Avian metapneumovirus (aMPV) is currently classified into four

30 enomic structure and composition of an avian metapneumovirus (aMPV) recently isolated from wild Canad

31 s counterpart from the closely related avian metapneumovirus (AMPV) subgroup C.

32 Avian metapneumovirus (aMPV) subtypes A and B were first detec

33 A serologically distinct avian metapneumovirus (aMPV) was isolated in the United States

34 Avian metapneumovirus (aMPV), also known as avian pneumovirus

35 riculturally important viruses such as avian metapneumovirus (aMPV), and Newcastle disease virus (NDV

36 bers, human metapneumovirus (hMPV) and avian metapneumovirus (aMPV), causing respiratory tract infect

37 al virus (hRSV), hMPV, bovine RSV, and avian metapneumovirus (aMPV).

38 al virus (hRSV), hMPV, bovine RSV, and avian metapneumovirus (aMPV).

39 The first cases of infection caused by avian metapneumoviruses (aMPVs) were described in turkeys with

40 teins from other subtype C viruses and human metapneumovirus and more than 170 aa larger than the G p

41 for two other respiratory pathogens - human metapneumovirus and seasonal coronavirus - from 35 US st

42 nome promoters are conserved between the two metapneumoviruses and can be cross-recognized by the pol

43 piratory syncytial viruses A and B and human metapneumovirus, and (iii) parainfluenza virus types 1 t

44 yncytial virus (RSV), influenza, rhinovirus, metapneumovirus, and adenovirus was highly associated wi

45 sts, including rhinovirus/enterovirus, human metapneumovirus, and coronavirus.

46 man rhinoviruses, human coronaviruses, human metapneumovirus, and human bocavirus, as well as the nee

47 nfluenza, respiratory syncytial virus, human metapneumovirus, and human rhinovirus) in a reconstitute

48 Coronaviruses, human metapneumovirus, and influenza A detections were usually

49 viruses, respiratory syncytial virus, human metapneumovirus, and the deadly zoonotic henipaviruses H

50 ding influenza virus, reovirus, HIV-1, human metapneumovirus, and vesicular stomatitis virus.

51 s, seasonal coronavirus, picornavirus, human metapneumovirus, and/or SARS-CoV-2 rapid antigen testing

52 Viral LRIs from rhinoviruses and human metapneumovirus are increasingly detected in children.

53 RTANCE Respiratory syncytial virus and human metapneumovirus are leading causes of respiratory illnes

54 ry syncytial virus, parainfluenza virus, and metapneumovirus are the most common viruses associated w

55 nued efforts to improve the outcome of human metapneumovirus-associated ALRI among young infants in l

56 , there were an estimated 14.2 million human metapneumovirus-associated ALRI cases (uncertainty range

57 6 100 overall (hospital and community) human metapneumovirus-associated ALRI deaths (5700 to 88 000).

58 ed ALRI in-hospital deaths and overall human metapneumovirus-associated ALRI deaths (both in-hospital

59 e aimed to estimate the age-stratified human metapneumovirus-associated ALRI global incidence, hospit

60 We also estimated human metapneumovirus-associated ALRI in-hospital deaths and o

61 ries are at greater risk of death from human metapneumovirus-associated ALRI than older children and

62 idence and hospital admission rates of human metapneumovirus-associated ALRI to population estimates

63 spital case-fatality ratios (hCFRs) of human metapneumovirus-associated ALRI using a generalised line

64 We estimated the global burden of human metapneumovirus-associated ALRIs in children younger tha

65 al admissions, and deaths by combining human metapneumovirus-associated burden estimates and attribut

66 10.2 million to 20.1 million), 643 000 human metapneumovirus-associated hospital admissions (UR 425 0

67 missions (UR 425 000 to 977 000), 7700 human metapneumovirus-associated in-hospital deaths (2600 to 4

68 Additionally, we estimated human metapneumovirus-attributable ALRI cases, hospital admiss

69 parainfluenza virus 3, influenza B and human metapneumovirus B.

70 etapneumovirus in laboratory-confirmed human metapneumovirus cases and deaths.

71 iruses not covered by DFA and R-mix culture (metapneumovirus, coronaviruses [CoV], parainfluenza viru

72 virus (82/556, 14.7%), coronavirus and human metapneumovirus (each 32/556, 5.6%).

73 tivity against RSV (EC(50) = 3-46 nM), human metapneumovirus (EC(50) = 210 nM), human rhinovirus (EC(

74 Metapneumovirus epidemics occurred in late winter and sp

75 The prefusion conformation of human metapneumovirus fusion protein (hMPV Pre-F) is critical

76 creening (OR 4.27), RSV (OR 2.46), and human metapneumovirus (HMPV) (OR 2.76).

77 The severity of the disease burden of human metapneumovirus (HMPV) among older adults is less well r

78 Paramyxoviridae includes two members, human metapneumovirus (hMPV) and avian metapneumovirus (aMPV),

79 Coronaviruses, human metapneumovirus (hMPV) and enteroviruses have also impac

80 Human metapneumovirus (HMPV) and human parainfluenza virus 3 (

81 Human metapneumovirus (HMPV) and human parainfluenza virus 3 (

82 re bronchiolitis and dual infection by human metapneumovirus (hMPV) and human respiratory syncytial v

83 matory chemokine production induced by human metapneumovirus (hMPV) and Nipah virus (NiV), suggesting

84 Human metapneumovirus (hMPV) and respiratory syncytial virus (

85 fections caused by the paramyxoviruses human metapneumovirus (hMPV) and respiratory syncytial virus (

86 eins derived from two human pathogens, human metapneumovirus (hMPV) and respiratory syncytial virus (

87 Human metapneumovirus (hMPV) and respiratory syncytial virus (

88 Respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) are closely related pathogens res

89 iratory syncytial virus (hRSV) and the human metapneumovirus (hMPV) are important human respiratory p

90 (RSV), parainfluenza virus (PIV), and human metapneumovirus (hMPV) are increasingly associated with

91 Respiratory syncytial virus (RSV) and human metapneumovirus (HMPV) are two closely related viruses t

92 Respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) are two important viral pathogens

93 Respiratory syncytial virus (RSV) and human metapneumovirus (HMPV) are two of the leading causes of

94 Here, using human metapneumovirus (HMPV) as a model, we demonstrate that m

95 Human metapneumovirus (hMPV) belongs to the Pneumoviridae fami

96 Respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) cause a similar spectrum of respi

97 Respiratory syncytial virus (RSV) and human metapneumovirus (HMPV) cause acute respiratory infection

98 Respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) cause human respiratory diseases

99 Respiratory syncytial virus (RSV) and human metapneumovirus (HMPV) cause severe respiratory diseases

100 Human metapneumovirus (HMPV) causes lower respiratory tract in

101 Human metapneumovirus (HMPV) causes significant upper and lowe

102 The M2 gene of human metapneumovirus (HMPV) contains two overlapping open rea

103 GFP-expressing AMPV and GFP-expressing human metapneumovirus (HMPV) could be recovered using the supp

104 DS-Cav1 vaccination also activated human metapneumovirus (HMPV) cross-reactive B cells capable of

105 Human metapneumovirus (HMPV) encodes three glycoproteins: the

106 Human metapneumovirus (hMPV) epidemiology, clinical characteri

107 In contrast, human metapneumovirus (HMPV) expressing only the F protein is

108 The phosphoprotein of human metapneumovirus (HMPV) forms homotetramers composed of a

109 respiratory syncytial virus (RSV) and human metapneumovirus (HMPV) from the 52060 respiratory sample

110 The human metapneumovirus (hMPV) fusion (F) protein is essential f

111 Human metapneumovirus (HMPV) has been identified as a worldwid

112 Human metapneumovirus (HMPV) has emerged as an important human

113 d understanding the immune response to human metapneumovirus (hMPV) has lagged behind, although hMPV

114 Human metapneumovirus (HMPV) has recently been identified as a

115 ent adult with asthma developed severe human metapneumovirus (HMPV) illness complicated by group A St

116 ent adult with asthma developed severe human metapneumovirus (HMPV) illness complicated by group A St

117 respiratory syncytial virus (RSV), or human metapneumovirus (hMPV) illness had pneumococcus detected

118 system resulted from the detection of human metapneumovirus (HMPV) in 9 specimens, human CoV (HCoV)

119 respiratory syncytial virus (RSV) and human metapneumovirus (HMPV) in older adults in comparison wit

120 SRs) (bioMerieux) for the detection of human metapneumovirus (hMPV) in respiratory samples.

121 y MAb-8 was evaluated for detection of human metapneumovirus (HMPV) in shell vial centrifugation cult

122 nocompromised hosts, but the impact of human metapneumovirus (hMPV) in this setting was previously un

123 Recombinant human metapneumovirus (HMPV) in which the SH, G, or M2 gene or

124 The inpatient and outpatient burden of human metapneumovirus (HMPV) infection among young children ha

125 Identified in 2001, human metapneumovirus (hMPV) infection can lead to hospitaliza

126 We determined the prevalence of human metapneumovirus (hMPV) infection in adults with asthma w

127 Human metapneumovirus (hMPV) infections have a significant imp

128 e clinical and genomic epidemiology of human metapneumovirus (hMPV) infections in community settings

129 Respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) infections pose a significant hea

130 IMPORTANCE Human metapneumovirus (HMPV) infects global populations, with

131 Human metapneumovirus (HMPV) is a common and globally prevalen

132 Human metapneumovirus (hMPV) is a common pathogen causing lowe

133 Human metapneumovirus (hMPV) is a frequent cause of acute resp

134 Human metapneumovirus (hMPV) is a frequent cause of bronchioli

135 Human metapneumovirus (HMPV) is a leading cause of acute lower

136 Human metapneumovirus (hMPV) is a leading cause of acute lower

137 Human metapneumovirus (HMPV) is a leading cause of acute respi

138 Human metapneumovirus (HMPV) is a leading cause of acute respi

139 Human metapneumovirus (HMPV) is a leading cause of acute respi

140 Human metapneumovirus (HMPV) is a leading cause of acute respi

141 Human metapneumovirus (HMPV) is a leading cause of acute respi

142 Human metapneumovirus (HMPV) is a leading cause of lower respi

143 Human metapneumovirus (hMPV) is a leading cause of morbidity a

144 Human metapneumovirus (hMPV) is a leading cause of respiratory

145 Human metapneumovirus (HMPV) is a leading cause of respiratory

146 Human metapneumovirus (hMPV) is a leading cause of respiratory

147 Human metapneumovirus (HMPV) is a leading cause of respiratory

148 Human metapneumovirus (HMPV) is a leading cause of respiratory

149 Human metapneumovirus (HMPV) is a leading cause of respiratory

150 Human metapneumovirus (hMPV) is a leading cause of viral lower

151 Human metapneumovirus (hMPV) is a major causative agent of upp

152 Human metapneumovirus (HMPV) is a major cause of respiratory d

153 Human metapneumovirus (HMPV) is a major cause of respiratory d

154 Human metapneumovirus (HMPV) is a major cause of respiratory i

155 Human metapneumovirus (hMPV) is a major cause of upper and low

156 Human metapneumovirus (HMPV) is a major etiologic agent of res

157 Human metapneumovirus (HMPV) is a major worldwide respiratory

158 Human metapneumovirus (hMPV) is a member of the Pneumovirinae

159 Human metapneumovirus (HMPV) is a negative-strand RNA virus th

160 Human metapneumovirus (hMPV) is a newly described paramyxoviru

161 Human metapneumovirus (hMPV) is a newly discovered paramyxovir

162 Human metapneumovirus (hMPV) is a newly identified human respi

163 Human metapneumovirus (hMPV) is a nonsegmented, single-strande

164 Human metapneumovirus (HMPV) is a paramyxovirus that causes re

165 Human metapneumovirus (hMPV) is a pathogen of worldwide import

166 Human metapneumovirus (HMPV) is a recently described human pat

167 Human metapneumovirus (hMPV) is a recently described member of

168 Human metapneumovirus (hMPV) is a recently described paramyxov

169 Human metapneumovirus (hMPV) is a recently described paramyxov

170 Human metapneumovirus (hMPV) is a recently described paramyxov

171 Human metapneumovirus (hMPV) is a recently discovered paramyxo

172 Human metapneumovirus (hMPV) is a recently discovered paramyxo

173 rtant clinical implications.IMPORTANCE Human metapneumovirus (HMPV) is a recently discovered pathogen

174 Human metapneumovirus (hMPV) is a recently discovered respirat

175 Human metapneumovirus (hMPV) is a recently discovered virus th

176 Human metapneumovirus (hMPV) is a relatively recently identifi

177 Human metapneumovirus (hMPV) is a respiratory paramyxovirus of

178 Human metapneumovirus (hMPV) is a respiratory paramyxovirus th

179 Human metapneumovirus (hMPV) is a respiratory virus detected i

180 Human metapneumovirus (hMPV) is a significant cause of acute r

181 Human metapneumovirus (HMPV) is a significant respiratory path

182 The recently identified human metapneumovirus (HMPV) is a worldwide respiratory virus

183 The M2-1 protein of human metapneumovirus (HMPV) is a zinc-binding transcription a

184 Human metapneumovirus (hMPV) is an important cause of acute vi

185 IMPORTANCE Human metapneumovirus (hMPV) is an important cause of viral re

186 Human metapneumovirus (HMPV) is now recognized to cause LRI il

187 espiratory syncytial virus (hRSV), the human metapneumovirus (hMPV) is one of the leading causes of c

188 Human metapneumovirus (hMPV) is one of the major causative age

189 respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) LRTI in premature children and de

190 A Light Diagnostics human metapneumovirus (HMPV) monoclonal antibody reagent was e

191 ural homology between the hRSV and the human metapneumovirus (hMPV) N(0)-P complexes.

192 The role that human metapneumovirus (hMPV) plays in the etiology of upper re

193 m effector proteins and SARS-CoV-2 and human metapneumovirus (HMPV) proteins in yeast to test their e

194 The burden of severe human metapneumovirus (HMPV) respiratory tract infections (RTI

195 challenging B cell-deficient mice with human metapneumovirus (HMPV) several weeks after primary infec

196 respiratory syncytial virus (hRSV) and human metapneumovirus (hMPV) share virologic and epidemiologic

197 Human metapneumovirus (hMPV) significantly impacts young child

198 oarray (Virochip) was used to detect a human metapneumovirus (hMPV) strain associated with a critical

199 98-75 (CAN75) and the CAN97-83 (CAN83) human metapneumovirus (HMPV) strains, which represent the two

200 activation of the fusion F protein of human metapneumovirus (HMPV) to replication and pathogenicity

201 roduction by BALB/c mice infected with human metapneumovirus (hMPV) was compared to respiratory syncy

202 Human metapneumovirus (hMPV) was identified in 2001 as a cause

203 Human metapneumovirus (HMPV) was initially identified as a cau

204 Human metapneumovirus (HMPV) was recently identified in The Ne

205 Chimeric versions of recombinant human metapneumovirus (HMPV) were generated by replacing the n

206 capability of MS for the detection of human metapneumovirus (HMPV), a common cause of respiratory tr

207 Human metapneumovirus (hMPV), a member of the family Paramyxov

208 Human metapneumovirus (hMPV), a recently described paramyxovir

209 Human metapneumovirus (hMPV), a recently discovered paramyxovi

210 Human metapneumovirus (HMPV), a recently discovered paramyxovi

211 Human metapneumovirus (hMPV), a recently discovered respirator

212 ry syncytial virus (RSV), enterovirus, human metapneumovirus (hMPV), adenovirus (AdV), and rhinovirus

213 irus (Flu), parainfluenza virus (PIV), human metapneumovirus (HMPV), adenovirus (AdV), rhinovirus (RV

214 Human metapneumovirus (HMPV), an emerging pathogen of this ord

215 onegavirales, namely, VSV, RABV, HRSV, human metapneumovirus (HMPV), and human parainfluenza virus (H

216 Respiratory syncytial virus (RSV), human metapneumovirus (HMPV), and human parainfluenza virus ty

217 an respiratory syncytial virus (hRSV), human metapneumovirus (hMPV), and human parainfluenza virus ty

218 influenza B virus, influenza A virus, human metapneumovirus (HMPV), and respiratory syncytial virus

219 es of the CAN97-83 clinical isolate of human metapneumovirus (HMPV), consensus nucleotide sequencing

220 Human metapneumovirus (HMPV), first identified in 2001, is a c

221 A recently discovered paramyxovirus, human metapneumovirus (hMPV), has been studied by our group in

222 Paramyxoviruses, including human metapneumovirus (HMPV), have evolved mechanisms to inhib

223 enovirus, coronaviruses HKU1 and NL63, human metapneumovirus (hMPV), influenza A virus (to type level

224 of respiratory syncytial virus (RSV), human metapneumovirus (HMPV), parainfluenza virus 1 to 3 (PIV1

225 Human metapneumovirus (HMPV), recently identified in isolates

226 tory syncytial virus (RSV), influenza, human metapneumovirus (HMPV), rhinovirus, and human parainflue

227 lu-B, PIV-1, PIV-2, PIV-3, PIV-4, RSV, human metapneumovirus (hMPV), rhinoviruses (RhVs), enterovirus

228 Human Parainfluenza Virus (HPIV), and Human Metapneumovirus (hMPV), we adopt a theoretical approach

229 us (RSV), coronavirus OC43 (OC43), and human metapneumovirus (HMPV).

230 piratory syncytial virus (RSV) but not human metapneumovirus (HMPV).

231 yncytial virus (RSV), mumps virus, and human metapneumovirus (HMPV).

232 OC43, 229E, NL63, and HKU1 (5.3%); and human metapneumovirus (HMPV; 5.0%).

233 spiratory syncytial viruses (HRSV) and human metapneumoviruses (HMPV) were involved in the etiology o

234 Human metapneumovirus (HMPVi) and parainfluenza virus (PIVi) i

235 Human metapneumoviruses (HMPVs) are recently identified Paramy

236 virus, human parainfluenza virus 1-4, human metapneumovirus, human coronaviruses (229E/OC43/NL63/HKU

237 as human respiratory syncytial virus, human metapneumovirus, human parainfluenza virus type 3, and m

238 fections (respiratory syncytial virus, human metapneumovirus, human rhinovirus, and adenovirus) were

239 We also detected human metapneumovirus in 15 percent of samples from 261 patien

240 1 600) could be causally attributed to human metapneumovirus in 2018.

241 re available for ALRIs associated with human metapneumovirus in children, and no licensed vaccines or

242 stimates and attributable fractions of human metapneumovirus in laboratory-confirmed human metapneumo

243 We sought to determine the role of human metapneumovirus in lower respiratory tract illness in pr

244 s during the cohort study, we detected human metapneumovirus in two chimpanzees from a February 2023

245 lex of respiratory syncytial virus and human metapneumovirus incorporate GS-646939 and ATP with simil

246 The mean age of human metapneumovirus-infected children was 11.6 months, the m

247 to functional spleen TCD8 in the same human metapneumovirus-infected mice.

248 Human metapneumovirus infection in the lower respiratory tract

249 We now find that human metapneumovirus infection induces virus-specific lung TC

250 Human metapneumovirus infection is a leading cause of respirat

251 red the gene expression of TCD8 during human metapneumovirus infection to those in acute or chronic l

252 isproportionately high risks of severe human metapneumovirus infections across all World Bank income

253 o licensed vaccines or drugs exist for human metapneumovirus infections.

254 by both commercial assays (adenovirus, human metapneumovirus, influenza A virus, influenza B virus, p

255 d 2013: adenovirus, human coronavirus, human metapneumovirus, influenza B virus and respiratory syncy

256 mary analysis tested negative for RSV, human metapneumovirus, influenza, and severe acute respiratory

257 Human metapneumovirus is a common virus associated with acute

258 Human metapneumovirus is a major cause of respiratory tract in

259 Human metapneumovirus is now recognized as a cause of lower re

260 and activities of CR-VI+, a portion of human Metapneumovirus L consisting of CR-VI and the poorly con

261 thelial cells or mice with recombinant human metapneumovirus lacking SH expression (rhMPV-DeltaSH) en

262 SARS-CoV-2 nucleocapsid protein and human metapneumovirus M2-1 protein are shown to enhance TBSV R

263 Human metapneumovirus may compound the clinical severity of pe

264 istence of two distinct sublineages of avian metapneumovirus (MPV) subtype C, a virus which has cause

265 es 1, 2, and 3 (PIV1, PIV2, and PIV3), human metapneumovirus (MPV), and adenovirus (AdV) in 1,138 spe

266 (RSV), parainfluenza virus, influenza virus, metapneumovirus (MPV), and coronavirus (CoV) detected in

267 eaction for RSV, PIV, influenza A and B, and metapneumovirus (MPV).

268 in 2022/2023, particularly for RSV and human metapneumovirus (n = 377 vs 93-127).

269 (respiratory syncytial virus [n = 3], human metapneumovirus [n = 1], and human coronavirus NL63 [n =

270 clinical testing (influenza A [n = 3], human metapneumovirus [n = 2], and human coronavirus OC43 [n =

271 yncytial virus, influenza viruses, and human metapneumovirus, often implicated as co-pathogens with p

272 e to TCD8 impairment induced by either human metapneumovirus or influenza virus infection.

273 utely in mice following infection with human metapneumovirus or influenza virus.

274 ory syncytial virus, parainfluenza virus, or metapneumovirus, or a combination of these, for at least

275 f 37 719 incident infections with RSV, human metapneumovirus, or human coronaviruses 229E, NL63, OC43

276 uses (ie, respiratory syncytial virus, human metapneumovirus, parainfluenza virus, and influenza viru

277 coronavirus, enteroviruses, influenza virus, metapneumovirus, parainfluenza virus, rhinovirus, and re

278 ytic choriomeningitis virus, measles, mumps, metapneumovirus, parainfluenza, rotavirus, respiratory s

279 rium effector proteins, SARS-CoV-2 and human metapneumovirus proteins in yeast to test their effects

280 viruses, coronavirus, rhinovirus, and human metapneumovirus, represent a considerable global health

281 d by the diagnostic panel (rhinovirus, human metapneumovirus, respiratory syncytial virus and parainf

282 za virus, coronaviruses, rhinoviruses, human metapneumovirus, respiratory syncytial virus, parainflue

283 spiratory syncytial virus, adenovirus, human metapneumovirus, rhinovirus, and influenza virus but not

284 e 248 specimens (20 percent) contained human metapneumovirus RNA or viable virus.

285 tion patterns, which were also seen in human metapneumovirus sequences, point to previously defined i

286 e but does not inhibit Sendai virus or human metapneumovirus, two paramyxoviruses.

287 were multibasic sequences derived from avian metapneumovirus type A (R-R-R-R) or type C (R-K-A-R), wi

288 Human metapneumovirus virus (hMPV) is a newly discovered respi

289 The distribution of metapneumovirus was bimodal, with the split being betwee

290 Metapneumovirus was detected in 11/391 specimens.

291 Human metapneumovirus was detected in BAL specimens from 5 of

292 A viral cause other than human metapneumovirus was determined for 279 of 687 visits for

293 parainfluenza virus, adenoviruses, and human metapneumovirus was lower in 2020 than 2019.

294 Human metapneumovirus was the commonest virus detected.

295 Higher viral loads of bocavirus and metapneumovirus were not significantly associated with a

296 enza, respiratory syncytial virus, and human metapneumovirus were substantially more common in patien

297 y tract illnesses were attributable to human metapneumovirus, which means that 12 percent of all lowe

298 st attachment (G) gene of any pneumovirus or metapneumovirus, with the predicted G protein of 585 ami

299 The genus Metapneumovirus within the subfamily Pneumovirinae of th

300 zuelan equine encephalitis virus, norovirus, metapneumovirus, yellow fever virus, Japanese encephalit